##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 155 No. 7 (2025)

Faecal incontinence in the era of sacral neuromodulation

Cite this as:
Swiss Med Wkly. 2025;155:4298
Published
24.07.2025

Summary

Faecal incontinence is a debilitating condition that significantly affects an individualʼs quality of life. Accurate assessment and a thorough understanding of the underlying aetiology are crucial in determining the appropriate management approach. Conservative management strategies, including dietary modifications, pelvic floor exercises and biofeedback therapy are the first therapeutic steps. If these measures are not effective, patients should be referred to a specialised pelvic floor centre for further treatment evaluations. With the latest updates on national and international guidelines, this review aims to provide a comprehensive overview of current best practices in the management of faecal incontinence, with a particular focus on the role of sacral neuromodulation.

References

  1. Whitehead WE, Simren M, Busby-Whitehead J, Heymen S, van Tilburg MA, Sperber AD, et al. Fecal incontinence diagnosed by the Rome IV criteria in the United States, Canada, and the United Kingdom. Clin Gastroenterol Hepatol. 2020 Feb;18(2):385–91. doi: https://doi.org/10.1016/j.cgh.2019.05.040
  2. Findlay JM, Maxwell-Armstrong C. Current issues in the management of adult faecal incontinence. Br J Hosp Med (Lond). 2010 Jun;71(6):335–40. doi: https://doi.org/10.12968/hmed.2010.71.6.48446
  3. Maslekar S, Gardiner A, Maklin C, Duthie GS. Investigation and treatment of faecal incontinence. Postgrad Med J. 2006 Jun;82(968):363–71. doi: https://doi.org/10.1136/pgmj.2005.044099
  4. Ahmad M, McCallum IJ, Mercer-Jones M. Management of faecal incontinence in adults. BMJ. 2010;340:c2964. doi: https://doi.org/10.1136/bmj.c2964
  5. Barrie M. Nursing management of patients with faecal incontinence. Nurs Stand. 2018 May;33(2):69–74. doi: https://doi.org/10.7748/ns.2018.e11167
  6. Lin AY, Varghese C, Paskaranandavadivel N, Seo S, Du P, Dinning P, et al. Faecal incontinence is associated with an impaired rectosigmoid brake and improved by sacral neuromodulation. Colorectal Dis. 2022 Dec;24(12):1556–66. doi: https://doi.org/10.1111/codi.16249
  7. Heitmann PT, Vollebregt PF, Knowles CH, Lunniss PJ, Dinning PG, Scott SM. Understanding the physiology of human defaecation and disorders of continence and evacuation. Nat Rev Gastroenterol Hepatol. 2021 Nov;18(11):751–69. doi: https://doi.org/10.1038/s41575-021-00487-5
  8. Cerdán J, Cerdán C, Jiménez F. Anatomofisiología de la continencia y la defecación [Anatomy and physiology of continence and defecation]. Cir Esp. 2005 Dec;78(3 Suppl 3):2–7. doi: https://doi.org/10.1016/S0009-739X(05)74637-6
  9. Norton C, Thomas L, Hill J; Guideline Development Group. Management of faecal incontinence in adults: summary of NICE guidance. BMJ. 2007 Jun;334(7608):1370–1. doi: https://doi.org/10.1136/bmj.39231.633275.AD
  10. Brown HW, Guan W, Schmuhl NB, Smith PD, Whitehead WE, Rogers RG. If we don’t ask, they won’t tell: screening for urinary and fecal incontinence by primary care providers. J Am Board Fam Med. 2018;31(5):774–82. doi: https://doi.org/10.3122/jabfm.2018.05.180045
  11. Goodman C, Norton C, Buswell M, Russell B, Harari D, Harwood R, et al. Managing Faecal INcontinence in people with advanced dementia resident in Care Homes (FINCH) study: a realist synthesis of the evidence. Health Technol Assess. 2017 Aug;21(42):1–220. doi: https://doi.org/10.3310/hta21420
  12. Bliss DZ, Savik K, Jung HJ, Whitebird R, Lowry A, Sheng X. Dietary fiber supplementation for fecal incontinence: a randomized clinical trial. Res Nurs Health. 2014 Oct;37(5):367–78. doi: https://doi.org/10.1002/nur.21616
  13. Markland AD, Burgio KL, Whitehead WE, Richter HE, Wilcox CM, Redden DT, et al. Loperamide versus psyllium fiber for treatment of fecal incontinence: the fecal incontinence prescription (Rx) management (FIRM) randomized clinical trial. Dis Colon Rectum. 2015 Oct;58(10):983–93. doi: https://doi.org/10.1097/DCR.0000000000000442
  14. Jelovsek JE, Markland AD, Whitehead WE, Barber MD, Newman DK, Rogers RG, et al.; National Institute of Child Health and Human Development Pelvic Floor Disorders Network. Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial. Lancet Gastroenterol Hepatol. 2019 Sep;4(9):698–710. doi: https://doi.org/10.1016/S2468-1253(19)30193-1
  15. George BD. Anal and perianal disorders. Medicine. 2011;39(2):84–9. doi: https://doi.org/10.1016/j.mpmed.2010.11.011
  16. Assmann SL, Keszthelyi D, Kleijnen J, Anastasiou F, Bradshaw E, Brannigan AE, et al. Guideline for the diagnosis and treatment of Faecal Incontinence-A UEG/ESCP/ESNM/ESPCG collaboration. United European Gastroenterol J. 2022 Apr;10(3):251–86. doi: https://doi.org/10.1002/ueg2.12213
  17. Wexner SD, Baeten C, Bailey R, Bakka A, Belin B, Belliveau P, et al. Long-term efficacy of dynamic graciloplasty for fecal incontinence. Dis Colon Rectum. 2002 Jun;45(6):809–18. doi: https://doi.org/10.1007/s10350-004-6302-1
  18. Katuwal B, Bhullar J. Corrigendum: Current Position of Sacral Neuromodulation in Treatment of Fecal Incontinence. Clinics in Colon and Rectal Surgery. 2021;34(01):e1-e.
  19. Jarrett ME, Mowatt G, Glazener CM, Fraser C, Nicholls RJ, Grant AM, et al. Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg. 2004 Dec;91(12):1559–69. doi: https://doi.org/10.1002/bjs.4796
  20. Uludağ O, Melenhorst J, Koch SM, van Gemert WG, Dejong CH, Baeten CG. Sacral neuromodulation: long-term outcome and quality of life in patients with faecal incontinence. Colorectal Dis. 2011 Oct;13(10):1162–6. doi: https://doi.org/10.1111/j.1463-1318.2010.02447.x
  21. Mellgren A, Wexner SD, Coller JA, Devroede G, Lerew DR, Madoff RD, et al.; SNS Study Group. Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum. 2011 Sep;54(9):1065–75. doi: https://doi.org/10.1097/DCR.0b013e31822155e9
  22. Dudding TC, Vaizey CJ, Kamm MA. Obstetric anal sphincter injury: incidence, risk factors, and management. Ann Surg. 2008 Feb;247(2):224–37. doi: https://doi.org/10.1097/SLA.0b013e318142cdf4
  23. Goetz LH, Lowry AC. Overlapping sphincteroplasty: is it the standard of care? Clin Colon Rectal Surg. 2005 Feb;18(1):22–31. doi: https://doi.org/10.1055/s-2005-864072
  24. Glasgow SC, Lowry AC. Long-term outcomes of anal sphincter repair for fecal incontinence: a systematic review. Dis Colon Rectum. 2012 Apr;55(4):482–90. doi: https://doi.org/10.1097/DCR.0b013e3182468c22
  25. Barisic GI, Krivokapic ZV, Markovic VA, Popovic MA. Outcome of overlapping anal sphincter repair after 3 months and after a mean of 80 months. Int J Colorectal Dis. 2006 Jan;21(1):52–6. doi: https://doi.org/10.1007/s00384-004-0737-7
  26. Mongardini FM, Cozzolino G, Karpathiotakis M, Cacciatore C, Docimo L. Short- and long-term outcomes of sphincteroplasty for anal incontinence related to obstetric injury: a systematic review. Updates Surg. 2023 Sep;75(6):1423–30. doi: https://doi.org/10.1007/s13304-023-01609-1
  27. Matzel KE, Stadelmaier U, Hohenberger W. Innovations in fecal incontinence: sacral nerve stimulation. Dis Colon Rectum. 2004 Oct;47(10):1720–8. doi: https://doi.org/10.1007/s10350-004-0636-6
  28. Hull T, Giese C, Wexner SD, Mellgren A, Devroede G, Madoff RD, et al.; SNS Study Group. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013 Feb;56(2):234–45. doi: https://doi.org/10.1097/DCR.0b013e318276b24c
  29. Janssen PT, Kuiper SZ, Stassen LP, Bouvy ND, Breukink SO, Melenhorst J. Fecal incontinence treated by sacral neuromodulation: long-term follow-up of 325 patients. Surgery. 2017 Apr;161(4):1040–8. doi: https://doi.org/10.1016/j.surg.2016.10.038
  30. Madoff RD, Parker SC, Varma MG, Lowry AC. Faecal incontinence in adults. Lancet. 2004 Aug;364(9434):621–32. doi: https://doi.org/10.1016/S0140-6736(04)16856-6
  31. Ratto C, Ganio E, Naldini G; GINS. Long-term results following sacral nerve stimulation for chronic constipation. Colorectal Dis. 2015 Apr;17(4):320–8. doi: https://doi.org/10.1111/codi.12857
  32. Dasgupta R, Critchley HD, Dolan RJ, Fowler CJ. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol. 2005 Dec;174(6):2268–72. doi: https://doi.org/10.1097/01.ju.0000181806.59363.d1
  33. Sharma A, Bussen D, Herold A, Jayne D. Review of sacral neuromodulation for management of constipation. Surg Innov. 2013 Dec;20(6):614–24. doi: https://doi.org/10.1177/1553350613475882
  34. Maeda Y, Kamm MA, Vaizey CJ, Matzel KE, Johansson C, Rosen H, et al. Long-term outcome of sacral neuromodulation for chronic refractory constipation. Tech Coloproctol. 2017 Apr;21(4):277–86. doi: https://doi.org/10.1007/s10151-017-1613-0
  35. Schwandner O. Sacral neuromodulation for fecal incontinence and “low anterior resection syndrome” following neoadjuvant therapy for rectal cancer. Int J Colorectal Dis. 2013 May;28(5):665–9. doi: https://doi.org/10.1007/s00384-013-1687-8
  36. Pires M, Severo M, Lopes A, Neves S, Matzel K, Povo A. Sacral neuromodulation for low anterior resection syndrome: current status-a systematic review and meta-analysis. Int J Colorectal Dis. 2023 Jul;38(1):189. doi: https://doi.org/10.1007/s00384-023-04485-8
  37. De Meyere C, Nuytens F, Parmentier I, D’Hondt M. Five-year single center experience of sacral neuromodulation for isolated fecal incontinence or fecal incontinence combined with low anterior resection syndrome. Tech Coloproctol. 2020 Sep;24(9):947–58. doi: https://doi.org/10.1007/s10151-020-02245-2
  38. Marinello F, Fraccalvieri D, Planellas P, Adell Trapé M, Gil JM, Kreisler E, et al. Sacral Neuromodulation in Patients With Low Anterior Resection Syndrome: The SANLARS Randomized Clinical Trial. Dis Colon Rectum. 2024 Mar;67(3):435–47. doi: https://doi.org/10.1097/DCR.0000000000003143
  39. Chan DK, Barker MA. Effective treatment of dyssynergic defecation using sacral neuromodulation in a patient with cerebral palsy. Female Pelvic Med Reconstr Surg. 2015;21(3):e27–9. doi: https://doi.org/10.1097/SPV.0000000000000147
  40. Widmann B, Galata C, Warschkow R, Beutner U, Ögredici Ö, Hetzer FH, et al. Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: a single-center follow-up study. J Neurogastroenterol Motil. 2019 Jan;25(1):159–70. doi: https://doi.org/10.5056/jnm17106
  41. Ganio E, Ratto C, Masin A, Luc AR, Doglietto GB, Dodi G, et al. Neuromodulation for fecal incontinence: outcome in 16 patients with definitive implant. The initial Italian Sacral Neurostimulation Group (GINS) experience. Dis Colon Rectum. 2001 Jul;44(7):965–70. doi: https://doi.org/10.1007/BF02235484
  42. Zbar AP. Sacral neuromodulation and peripheral nerve stimulation in patients with anal incontinence: an overview of techniques, complications and troubleshooting. Gastroenterol Rep (Oxf). 2014 May;2(2):112–20. doi: https://doi.org/10.1093/gastro/gou015
  43. Spinelli M, Sievert KD. Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol. 2008 Dec;54(6):1287–96. doi: https://doi.org/10.1016/j.eururo.2008.01.076